Rich L F, Hatfield J M, Louiselle I
Department of Ophthalmology, Casey Eye Institute, Oregon Health Sciences University, Portland 97201-3098.
Curr Eye Res. 1991 Sep;10(9):823-30. doi: 10.3109/02713689109013878.
Using standardized freeze wounds in cat corneas, we tested the efficacy of human recombinant Epidermal Growth Factor (EGF) to promote endothelial healing when solubilized in either phosphate buffered saline (PBS), 1% methylcellulose (MC), or sodium hyaluronate (NaHA), in final intraocular doses ranging from 2 micrograms to 100 micrograms of EGF. After 6 or 7 days' healing, animals were humanely sacrificed and corneal tissues were fixed and stained for light microscopy and computation of remaining wound areas. EGF in NaHA in final intraocular doses of 2 and 10 micrograms prompted significantly more complete healing of transcorneal freeze wounds to endothelium compared with endothelium of eyes treated with NaHA control solution alone. EGF in PBS or in MC in doses ranging from 2-100 micrograms/eye did not promote more complete wound healing than that seen in eyes treated with their respective vehicle solutions alone. All vehicle solutions were associated with similar degrees of wound healing, implying that they have no intrinsic healing properties.
我们在猫角膜上制作标准化的冷冻伤口,测试了人重组表皮生长因子(EGF)分别溶解于磷酸盐缓冲盐水(PBS)、1%甲基纤维素(MC)或透明质酸钠(NaHA)中时,眼内最终剂量范围为2微克至100微克的EGF促进内皮愈合的效果。在愈合6或7天后,对动物实施安乐死,固定角膜组织并进行染色,以便进行光学显微镜检查和计算剩余伤口面积。与仅用NaHA对照溶液处理的眼睛的内皮相比,最终眼内剂量为2微克和10微克的NaHA中的EGF促使经角膜冷冻伤口至内皮的愈合明显更完全。剂量范围为2 - 100微克/眼的PBS或MC中的EGF与仅用各自赋形剂溶液处理的眼睛相比,并未促进更完全的伤口愈合。所有赋形剂溶液都与相似程度的伤口愈合相关,这意味着它们没有内在的愈合特性。